Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Solicitation opportunity from Department Of Defense was posted on August 26, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Ondansetron HCL Tablets

Closed
SPE2D2-25-R-0017Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The Defense Logistics Agency (DLA) is set to issue a solicitation for a national requirements contract to supply Ondansetron Hydrochloride (HCL) Tablets in various strengths and packaging sizes, including 4 mg tablets in 30, 100, and 500 count bottles, and 8 mg tablets in 30 and 500 count bottles. This procurement will be unrestricted and fully competitive, utilizing a firm-fixed-price, requirements-type contract structure with a one-year base period plus four one-year option periods. The contract will support multiple government agencies including the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons, providing the medication through DLA and VA prime vendor programs. The contract is classified as a commercial item acquisition and will be conducted under FAR Part 12. Annual usage estimates will be detailed in the solicitation’s Schedule of Supplies. The current projected solicitation release date is July 2025, although the DLA reserves the right to adjust this timeline. Interested vendors are encouraged to monitor updates on the DLA Bid Board System (DIBBS) and Sam.gov, and to register for automated notifications. Questions should be directed to the designated points of contact at DLA. Notably, Ondansetron orally dissolving tablets, initially part of this procurement, will be addressed in a separate solicitation.

General Info

DLA seeks suppliers for Ondansetron HCL tablets, firm-fixed-price, one-year plus options, multiple agencies.

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

PA

Set-Aside

NONE

Documents

1

Ondansetron HCL National Contract Solicitation SPE2D2-25-R-0017

PDF, High priority: read this firstrfp
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

1 update
PhaseClosed
Posted

Presolicitation

Notice updated

The notice title changed. The notice description changed. The point of contact changed.

Type Changed

Presolicitation → Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → DLA Troop Support
Contacts2 people available
OfficePHILADELPHIA, PA, 19111, USA
Office AddressPHILADELPHIA, PA, 19111, USA

Full Description

Show more

Solicitation is attached.

More opportunities from Department Of Defense → DLA Troop Support

Same awarding agency

NAICS: 326199
New
Federal
Synopsis for Outserts (NSN - 4240-01-529-8327 & 4240-01-528-9288)
Solicitation # 015298327_015289288
Solicitation SPE8EG-26-R-0003 is an unrestricted, fixed-price with economic price adjustment, indefinite delivery/indefinite quantity contract issued by DLA Troop Support. The procurement is for critical Chemical Biological Radiation and Nuclear Personal Protective Equipment, specifically Clear Assembly Outserts (NSN 4240-01-529-8327) and Laser Assembly Outserts (NSN 4240-01-528-9288). The contract structure consists of a one-year base period and four one-year option periods, with a target delivery schedule of 100 days and terms set as FOB Origin. Avon Protection Systems Incorporated is the approved source, and while alternate offers are encouraged via specific DLAD procurement notes, they require a complete data package for evaluation. The solicitation has undergone five amendments, with the final closing date extended to September 2, 2026, at 3:00 PM EDT. Key regulatory requirements include compliance with the Buy American Act, the Berry Amendment, and export-control regulations under ITAR and EAR, requiring offerors to have approved US/Canada Joint Certification Program certification. Additionally, the contract incorporates FAR 52.222-90 regarding DEI discrimination and clarifies that while Cybersecurity Maturity Model Certification Level 2 is not required for the initial award, it may be necessary for future continued performance. Price is the sole evaluated factor for award.
All Other Plastics Product Manufacturing

POSTED

about 20 hours ago

DEADLINE

in 16 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS